Monday - November 18, 2024
Paul Hastings Advised Global Coordinators, Bookrunners in Connection With GenSight Biologics' PIPE Financing
May 11, 2024
LOS ANGELES, California, May 11 -- Paul Hastings, a law firm, issued the following news:

Paul Hastings LLP advised Chardan Capital Markets and Invest Securities as joint global coordinators and bookrunners in connection with GenSight Biologics' private placement (PIPE).

GenSight Biologics (Euronext: SIGHT) is a French biopharma company focused on developing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders.

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products